We observed a significantly higher relative methylation level in the first region of the DICER promoter in lung cancer patients (p = 0.029, Figure 1C) and in NSCLC patients (p = 0.018, Figure 1F) compared to healthy people (Figure 1). The gene discussed is DICER1; the disease is non-small cell lung carcinoma.